
Anaconda Biomed is a Spanish medical device company developing funnel catheter technology for stroke treatment.
Anaconda Biomed, S.L. is a medical device company headquartered in Sant Quirze del Vallès, Barcelona, Spain, focused on next-generation endovascular access and protection in neurovascular care. Its funnel catheter platform is designed for mechanical thrombectomy in large vessel occlusion ischemic stroke, combining high-efficiency aspiration, controlled flow arrest, and clot capture in a self-expanding nitinol funnel. The lead product, the ANA5 Funnel Catheter, carries CE marking for European distribution and is studied in United States clinical trials, where it remains investigational.
The company was co-founded by Marc Ribó and Ofir Arad and operates its own development and manufacturing near Barcelona. Its clinical program includes the ATHENA randomized pivotal trial in the United States and earlier published results of the ANAIS study of the funnel catheter. Backers include international and Spanish life science investors such as Omega Funds, Asabys Partners, and Ysios Capital.
Anaconda Biomed's most recent funding round was for $56M (USD) in September 2026.
As of Sep 23, 2026, Anaconda Biomed has disclosed funding of $145.5M (USD).

Route 92 Medical
r92m.com
Palmera Medical

NeuRx Medical
neurxmed.com
Advanced Catheter Therapies
acatheter.com

Akura Medical
akuramedical.com
NeuroFine
neurofine.com

Q'Apel Medical
qapelmedical.com

MIVI Neuroscience
mivineuro.com

Cognition Medical

Bi02 Medical
bio2medical.com

Rapidpulse
rapidpulsemed.com

Conformal Medical

Thrombolex
thrombolex.com

NeuroVasc Technologies

Vena Medical
venamed.ca
Capture Vascular

Cagent Vascular
cagentvascular.com

Piraeus Medical
piraeusmedical.com

Endovascular Engineering

Flow Medical
flowmedical.co